Delegation of Authority to the Chief Accountant, 2805-2807 [2011-835]
Download as PDF
2805
Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Rules and Regulations
Accordingly, part 748 of the EAR (15
CFR Parts 730–774) is amended as
follows:
PART 748—[AMENDED]
1. The authority citation for 15 CFR
Part 748 continues to read as follows:
■
Authority: 50 U.S.C. app. 2401 et seq.; 50
U.S.C. 1701 et seq.; E.O. 13026, 61 FR 58767,
3 CFR, 1996 Comp., p. 228; E.O. 13222, 66
FR 44025, 3 CFR, 2001 Comp., p. 783; Notice
of August 12, 2010, 75 FR 50681 (August 16,
2010).
‘‘China (People’s Republic of)’’ to read as
follows:
2. Supplement No. 7 to Part 748 is
amended:
■ a. By adding one entry, ‘‘CSMC
Technologies Corporation’’, for ‘‘China
(People’s Republic of)’’ in alphabetical
order; and
■ b. By revising the entry for ‘‘Advanced
Micro Devices (Shanghai) Co., Ltd.’’ for
SUPPLEMENT NO. 7 TO PART 748—
AUTHORIZATION VALIDATED ENDUSER (VEU); LIST OF VALIDATED
END-USERS, RESPECTIVE ITEMS
ELIGIBLE FOR EXPORT, REEXPORT
AND TRANSFER, AND ELIGIBLE
DESTINATIONS
■
Country
Validated end-user
Eligible items (by ECCN)
Eligible destination
China (People’s
Republic of).
Advanced Micro Devices China, Inc. .......................
3D002, 3D003, 3E001 (limited to
‘‘technology’’ for items classified
under 3C002 and 3C004 and
‘‘technology’’ for use during the
International Technology Roadmap for Semiconductors (ITRS)
process for items classified
under ECCNs 3B001 and
3B002), 3E002 (limited to
‘‘technology’’ for use during the
ITRS process for items classified under ECCNs 3B001 and
3B002), 3E003.e (limited to the
‘‘development’’ and ‘‘production’’
of integrated circuits for commercial applications), 4D001,
4D002, 4D003 and 4E001 (limited to the ‘‘development’’ of
products under ECCN 4A003).
AMD Technologies (China) Co.,
Ltd., No. 88, Su Tong Road,
Suzhou, China 215021.
Advanced Micro Devices (Shanghai) Co., Ltd., Buildings 46, 47,
48 & 49, River Front Harbor,
Zhangjiang Hi-Tech Park, 1387
Zhangdong
Rd.,
Pudong,
Shanghai, 201203.
AMD Technology Development
(Beijing) Co., Ltd., 18F, North
Building, Raycom Infotech, Park
Tower C, No. 2 Science Institute South Rd., Zhong Guan
Cun, Haidian District, Beijing,
China 100190.
*
*
*
*
CSMC Technologies Corporation ............................. 1C350.c.3, 1C350.c.11, 2B230.a,
2B230.b, 2B350.f, 2B350.g,
2B350.h,
3B001.c.1.a,
3B001.c.2.a, 3B001.e, 3C002.a,
3C004.
*
*
CSMC Technologies Fab 1 Co.,
Ltd., 14 Liangxi Road, Wuxi,
Jiangsu 214061, China.
CSMC, Technologies Fab 2 Co.,
Ltd., Block 86, 87, Wuxi National Hi-New Tech Industrial
Development
Zone,
Wuxi,
Jiangsu 214061, China.
Wuxi CR Semiconductor Wafers
and Chips Co., Ltd., 14 Liangxi
Road, Wuxi, Jiangsu 214061,
China.
*
*
*
*
Dated: January 11, 2011.
Kevin J. Wolf,
Assistant Secretary for Export
Administration.
BILLING CODE 3510–33–P
SECURITIES AND EXCHANGE
COMMISSION
WReier-Aviles on DSKDVH8Z91PROD with RULES
17 CFR Part 200
[Release No. 34–63699]
Delegation of Authority to the Chief
Accountant
Securities and Exchange
Commission.
ACTION: Final rule.
AGENCY:
13:37 Jan 14, 2011
*
The Securities and Exchange
Commission is amending its rules to
delegate authority to the Chief
Accountant with respect to proposed
rule changes of the Public Company
Accounting Oversight Board pursuant to
Section 107 of the Sarbanes-Oxley Act
of 2002 and Section 19(b) of the
Securities Exchange Act of 1934, as
follows: To publish notices of proposed
rule changes filed by the PCAOB; to
approve or disapprove a proposed rule
change; and to temporarily suspend a
proposed rule of the PCAOB. In
addition, the Commission is amending
its rules to delegate authority to the
Chief Accountant to determine the
appropriateness of extending the time
periods specified in Section 19(b) and
publish the reasons for such
determination as well as to effect any
SUMMARY:
[FR Doc. 2011–920 Filed 1–14–11; 8:45 am]
VerDate Mar<15>2010
*
Jkt 223001
PO 00000
Frm 00007
Fmt 4700
Sfmt 4700
*
*
such extension and to institute
proceedings to determine whether to
disapprove a proposal and to provide to
the PCAOB notice of the grounds for
disapproval under consideration, and to
find good cause to approve a proposal
on an accelerated basis and to publish
the reasons for such determination. This
delegation is intended to conserve
Commission resources and to maintain
the effectiveness and efficiency of the
Commission’s PCAOB proposed rule
filing process.
DATES:
Effective Date: January 18, 2011.
FOR FURTHER INFORMATION CONTACT:
Jeffrey S. Cohan, Senior Special
Counsel, or John F. Offenbacher, Senior
Associate Chief Accountant, at (202)
551–5300, Office of the Chief
Accountant, Securities and Exchange
E:\FR\FM\18JAR1.SGM
18JAR1
2806
Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Rules and Regulations
Commission, 100 F Street, NE.,
Washington, DC 20549–7561.
SUPPLEMENTARY INFORMATION:
WReier-Aviles on DSKDVH8Z91PROD with RULES
I. Discussion of Rule Amendments
Pursuant to the Sarbanes-Oxley Act of
2002 (‘‘Sarbanes-Oxley Act’’),1 proposed
rules of the Public Company Accounting
Oversight Board (‘‘PCAOB’’) are
governed by certain provisions of
Section 19 of the Securities Exchange
Act of 1934 (‘‘Exchange Act’’).2 The
Dodd-Frank Wall Street Reform and
Consumer Protection Act 3 amended
Section 19 of the Exchange Act so that
there are new deadlines by which the
Securities and Exchange Commission
(‘‘Commission’’) must publish and act
upon proposed rule changes submitted
by the PCAOB. In recognition of the
amendments to Section 19, the
Commission is amending its rules
governing delegations of authority to the
Chief Accountant. The amendments to
Rule 30–11 (17 CFR 200.30–11)
authorize the Chief Accountant: (1) To
publish notice of a PCAOB proposed
rule change pursuant to Section
19(b)(1); (2) pursuant to Section 19(b)(2)
of the Exchange Act, to approve or
disapprove 4 a PCAOB proposed rule
change; 5 (3) pursuant to Section
19(b)(2)(A) of the Exchange Act,6 to
extend for a period not exceeding 90
days from the date of publication of
notice of the filing of a proposed rule
change the period during which the
Commission must by order approve or
disapprove the proposed rule change;
(4) pursuant to Section 19(b)(2)(A) of the
Exchange Act,7 to determine the
appropriateness of extending the period
during which the Commission must by
1 See Section 107 of the Sarbanes-Oxley Act, 15
U.S.C. 7217.
2 See 15 U.S.C. 78s(b)(2).
3 Dodd-Frank Wall Street Reform and Consumer
Protection Act, Pub. L. 111–203, 124 Stat. 1376
(2010).
4 15 U.S.C. 78s(b)(2). Section 107(b) of the
Sarbanes Oxley Act, 15 U.S.C. 7217(b), and Section
19(b)(2)(C) of the Exchange Act, 15 U.S.C.
78s(b)(2)(C), provide the standards for Commission
approval and disapproval of a proposed rule.
Specifically, Section 107(b)(3) provides that the
Commission ‘‘shall approve a proposed rule if it
finds that the rule is consistent with the
requirements of this Act and the securities laws, or
is necessary and appropriate in the public interest
or for the protection of investors.’’ Additionally, the
Commission may not approve a proposed rule
change earlier than 30 days after the date of
publication unless the Commission finds good
cause for so doing and publishes the reasons for the
finding.
5 The amendments also specify that the Office of
the Chief Accountant is to notify the Commission
no less than five (5) business days before the Chief
Accountant intends to exercise his or her authority
to approve or disapprove a particular proposed rule
change.
6 15 U.S.C. 78s(b)(2)(A).
7 15 U.S.C. 78s(b)(2)(A).
VerDate Mar<15>2010
13:37 Jan 14, 2011
Jkt 223001
order approve or disapprove a proposed
rule change or institute proceedings to
determine whether to disapprove the
proposal and publish the reasons for
such determination; (5) pursuant to
Section 19(b)(2)(B) of the Exchange
Act,8 to extend for a period not
exceeding 240 days from the date of
publication of notice of the filing of a
proposed rule change the period during
which the Commission must conclude
proceedings to determine whether to
disapprove the proposal and to
determine whether such longer period is
appropriate and publish the reasons for
such determination; (6) to temporarily
suspend the PCAOB’s proposed rule
change pursuant to Section 19(b)(3)(C)
of the Exchange Act; 9 (7) pursuant to
Section 19(b)(2) of the Exchange Act
and 19(b)(3) of the Exchange Act, to
institute proceedings to determine
whether a proposed rule of the PCAOB
should be disapproved and to provide to
the PCAOB notice of the grounds for
disapproval under consideration; and
(8) to find good cause to approve a
proposal on an accelerated basis and to
publish the reasons for such
determination.
This delegation is intended to
conserve Commission resources and
maintain the effectiveness and
efficiency of the Commission’s process
for handling proposed rule changes
submitted by the PCAOB. The
Commission anticipates that the
delegation of authority will help
facilitate timely compliance with the
amendments to Section 19 of the
Exchange Act and the new statutory
deadlines prescribed therein.
Nevertheless, the Chief Accountant may
submit matters to the Commission for its
consideration, as he or she deems
appropriate.
The Commission finds, in accordance
with the Administrative Procedure Act
(5 U.S.C. 553(b)(3)(A)), that these
amendments relate solely to agency
organization, procedures, or practices,
and do not relate to a substantive rule.
Accordingly, notice, opportunity for
public comment, and publication of the
amendments prior to their effective date
are unnecessary and these changes are
effective on January 18, 2011.
List of Subjects in 17 CFR Part 200
Administrative practice and
procedure, Authority delegations
(Government agencies).
Text of Amendment
For the reasons set out in the
preamble, Title 17, Chapter II of the
8 15
9 15
PO 00000
U.S.C. 78s(b)(2)(B).
U.S.C. 78s(b)(3)(C).
Frm 00008
Fmt 4700
Sfmt 4700
Code of Federal Regulations is amended
as follows:
PART 200—ORGANIZATION;
CONDUCT AND ETHICS; AND
INFORMATION AND REQUESTS
1. The authority citation for Part 200,
Subpart A, continues to read in part as
follows:
■
Authority: 15 U.S.C. 77o, 77s, 77sss, 77d,
78d–1, 78d–2, 78w, 78ll(d), 78mm, 80a–37,
80b–11, and 7202 et seq., unless otherwise
noted.
*
*
*
*
*
2. Section 200.30–11 is amended as
follows:
■ a. Redesignating paragraph (b) as
paragraph (c).
■ b. Adding new paragraph (b).
The addition reads as follows:
■
§ 200.30–11 Delegation of authority to the
Chief Accountant.
*
*
*
*
*
(b)(1) Pursuant to section 107 of the
Sarbanes-Oxley Act of 2002, 15 U.S.C.
7217, and section 19(b) of the Act, 15
U.S.C. 78s(b), and applicable rules of
the Commission, to publish notices of
proposed rule changes filed by the
Public Company Accounting Oversight
Board.
(2) Pursuant to section 107 of the
Sarbanes-Oxley Act of 2002, 15 U.S.C.
7217, and section 19(b) of the Act, 15
U.S.C. 78s(b), and applicable rules of
the Commission, to approve or
disapprove a proposed rule change, and
to find good cause to approve a
proposed rule change earlier than 30
days after the date of publication of
such proposed rule change and to
publish the reasons for such finding.
The Office of the Chief Accountant shall
notify the Commission no less than five
(5) business days before the Chief
Accountant intends to exercise his or
her authority to approve or disapprove
a particular proposed rule change.
(3) Pursuant to section 107 of the
Sarbanes-Oxley Act of 2002, 15 U.S.C.
7217, and section 19(b)(2)(A) of the Act,
15 U.S.C. 78s(b)(2)(A), to extend for a
period not exceeding 90 days from the
date of publication of notice of the filing
of a proposed rule change pursuant to
section 19(b)(1) of the Act, 15 U.S.C.
78s(b)(1), the period during which the
Commission must by order approve or
disapprove the proposed rule change or
institute proceedings to determine
whether the proposed rule change
should be disapproved and to determine
whether such longer period is
appropriate and publish the reasons for
such determination.
(4) Pursuant to section 107 of the
Sarbanes-Oxley Act of 2002, 15 U.S.C.
E:\FR\FM\18JAR1.SGM
18JAR1
2807
Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Rules and Regulations
7217, section 19(b)(2) of the Act, 15
U.S.C. 78s(b)(2), and section 19(b)(3) of
the Act, 15 U.S.C. 78s(b)(3), to institute
proceedings to determine whether a
proposed rule change of the Public
Company Accounting Oversight Board
should be disapproved and to provide to
the Public Company Accounting
Oversight Board notice of the grounds
for disapproval under consideration. In
addition, pursuant to section 107 of the
Sarbanes-Oxley Act of 2002, 15 U.S.C.
7217, and section 19(b)(2)(B) of the Act,
15 U.S.C. 78s(b)(2)(B), to extend for a
period not exceeding 240 days from the
date of publication of notice of the filing
of a proposed rule change pursuant to
section 19(b)(1) of the Act, 15 U.S.C.
78s(b)(1), the period during which the
Commission must issue an order
approving or disapproving the proposed
rule change and to determine whether
such longer period is appropriate and
publish the reasons for such
determination.
(5) Pursuant to section 107 of the
Sarbanes-Oxley Act of 2002, 15 U.S.C.
7217, and section 19(b)(3)(C) of the Act,
15 U.S.C. 78s(b)(3)(C), to temporarily
suspend a rule of the Public Company
Accounting Oversight Board.
*
*
*
*
*
Dated: January 11, 2011.
By the Commission.
Elizabeth M. Murphy,
Secretary.
Biopure
Corp., 11 Hurley St., Cambridge, MA
02141 has informed FDA that it has
transferred ownership of, and all rights
and interest in, NADA 141–067 for
OXYGLOBIN (hemoglobin glutamer200) to OPK Biotech, LLC, 11 and 39
Hurley St., Cambridge, MA 02141.
There is no change in drug labeler code.
Following this change of sponsorship,
Biopure Corp. is no longer the sponsor
of an approved application. In addition,
OPK Biotech, LLC, is not currently
listed in the animal drug regulations as
a sponsor of an approved application.
Accordingly, § 510.600 is being
amended to reflect these changes.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
SUPPLEMENTARY INFORMATION:
List of Subjects in 21 CFR Part 510
Administrative practice and
procedure, Animal drugs, Labeling,
Reporting and recordkeeping
requirements.
Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR part 510 is amended as follows:
[FR Doc. 2011–835 Filed 1–14–11; 8:45 am]
1. The authority citation for 21 CFR
part 510 continues to read as follows:
■
Authority: 21 U.S.C. 321, 331, 351, 352,
353, 360b, 371, 379e.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
21 CFR Part 510
[Docket No. FDA–2010–N–0002]
New Animal Drugs; Change of Sponsor
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
2. In § 510.600, in the table in
paragraph (c)(1), remove the entry for
‘‘Biopure Corp.’’; and alphabetically add
a new entry for ‘‘OPK Biotech, LLC’’; and
in the table in paragraph (c)(2), revise
the entry for ‘‘063075’’ to read as
follows:
■
Food and Drug Administration
Final rule.
§ 510.600 Names, addresses, and drug
labeler codes of sponsors of approved
applications.
*
The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect a
change of sponsor for hemoglobin
glutamer-200 from Biopure Corp. to
OPK Biotech, LLC.
DATES: This rule is effective January 18,
2011.
FOR FURTHER INFORMATION CONTACT:
Steven D. Vaughn, Center for Veterinary
Medicine (HFV–100), Food and Drug
Administration, 7520 Standish Pl.,
Rockville, MD 20855, 240–276–8300,
e-mail: steven.vaughn@fda.hhs.gov.
WReier-Aviles on DSKDVH8Z91PROD with RULES
SUMMARY:
VerDate Mar<15>2010
13:59 Jan 14, 2011
Jkt 223001
*
*
(c) * * *
(1) * * *
*
*
Drug
labeler
code
Firm name and address
*
*
*
*
OPK Biotech, LLC, 11 and 39
Hurley St., Cambridge, MA
02141 ........................................
PO 00000
*
*
*
*
(2) * * *
Frm 00009
Fmt 4700
Sfmt 4700
Firm name and address
*
063075
*
*
*
*
OPK Biotech, LLC, 11 and 39
Hurley St., Cambridge, MA
02141
*
*
*
063075
*
*
*
*
Dated: January 11, 2011.
Steven D. Vaughn,
Director, Office of New Animal Drug
Evaluation, Center for Veterinary Medicine.
[FR Doc. 2011–904 Filed 1–14–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 510 and 522
[Docket No. FDA–2010–N–0002]
New Animal Drugs; Change of
Sponsor; Follicle Stimulating Hormone
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Final rule.
The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect a
change of sponsor for a new animal drug
application (NADA) for follicle
stimulating hormone from Ausa
International, Inc., to Therio, Inc.
DATES: This rule is effective January 18,
2011.
FOR FURTHER INFORMATION CONTACT:
Steven D. Vaughn, Center for Veterinary
Medicine (HFV–100), Food and Drug
Administration, 7520 Standish Pl.,
Rockville, MD 20855, 240–276–8300,
e-mail: steven.vaughn@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Ausa
International, Inc., Rt. 8, P.O. Box 324–
12, Tyler, TX 75703 has informed FDA
that it has transferred ownership of, and
all rights and interest in, NADA 141–
014 for SUPER–OV (follicle stimulating
hormone) to Therio, Inc., 8801
Anderson Ave., Manhattan, KS 66503.
Accordingly, the Agency is amending
the regulations in 21 CFR 522.1002 to
reflect the transfer of ownership.
Following this change of sponsorship,
Ausa International, Inc., is no longer the
sponsor of an approved application.
Accordingly, § 510.600 (21 CFR
510.600) is being amended to remove
the entries for this firm.
SUMMARY:
PART 510—NEW ANIMAL DRUGS
BILLING CODE 8011–01–P
Drug labeler
code
E:\FR\FM\18JAR1.SGM
18JAR1
Agencies
[Federal Register Volume 76, Number 11 (Tuesday, January 18, 2011)]
[Rules and Regulations]
[Pages 2805-2807]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-835]
=======================================================================
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
17 CFR Part 200
[Release No. 34-63699]
Delegation of Authority to the Chief Accountant
AGENCY: Securities and Exchange Commission.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Securities and Exchange Commission is amending its rules
to delegate authority to the Chief Accountant with respect to proposed
rule changes of the Public Company Accounting Oversight Board pursuant
to Section 107 of the Sarbanes-Oxley Act of 2002 and Section 19(b) of
the Securities Exchange Act of 1934, as follows: To publish notices of
proposed rule changes filed by the PCAOB; to approve or disapprove a
proposed rule change; and to temporarily suspend a proposed rule of the
PCAOB. In addition, the Commission is amending its rules to delegate
authority to the Chief Accountant to determine the appropriateness of
extending the time periods specified in Section 19(b) and publish the
reasons for such determination as well as to effect any such extension
and to institute proceedings to determine whether to disapprove a
proposal and to provide to the PCAOB notice of the grounds for
disapproval under consideration, and to find good cause to approve a
proposal on an accelerated basis and to publish the reasons for such
determination. This delegation is intended to conserve Commission
resources and to maintain the effectiveness and efficiency of the
Commission's PCAOB proposed rule filing process.
DATES: Effective Date: January 18, 2011.
FOR FURTHER INFORMATION CONTACT: Jeffrey S. Cohan, Senior Special
Counsel, or John F. Offenbacher, Senior Associate Chief Accountant, at
(202) 551-5300, Office of the Chief Accountant, Securities and Exchange
[[Page 2806]]
Commission, 100 F Street, NE., Washington, DC 20549-7561.
SUPPLEMENTARY INFORMATION:
I. Discussion of Rule Amendments
Pursuant to the Sarbanes-Oxley Act of 2002 (``Sarbanes-Oxley
Act''),\1\ proposed rules of the Public Company Accounting Oversight
Board (``PCAOB'') are governed by certain provisions of Section 19 of
the Securities Exchange Act of 1934 (``Exchange Act'').\2\ The Dodd-
Frank Wall Street Reform and Consumer Protection Act \3\ amended
Section 19 of the Exchange Act so that there are new deadlines by which
the Securities and Exchange Commission (``Commission'') must publish
and act upon proposed rule changes submitted by the PCAOB. In
recognition of the amendments to Section 19, the Commission is amending
its rules governing delegations of authority to the Chief Accountant.
The amendments to Rule 30-11 (17 CFR 200.30-11) authorize the Chief
Accountant: (1) To publish notice of a PCAOB proposed rule change
pursuant to Section 19(b)(1); (2) pursuant to Section 19(b)(2) of the
Exchange Act, to approve or disapprove \4\ a PCAOB proposed rule
change; \5\ (3) pursuant to Section 19(b)(2)(A) of the Exchange Act,\6\
to extend for a period not exceeding 90 days from the date of
publication of notice of the filing of a proposed rule change the
period during which the Commission must by order approve or disapprove
the proposed rule change; (4) pursuant to Section 19(b)(2)(A) of the
Exchange Act,\7\ to determine the appropriateness of extending the
period during which the Commission must by order approve or disapprove
a proposed rule change or institute proceedings to determine whether to
disapprove the proposal and publish the reasons for such determination;
(5) pursuant to Section 19(b)(2)(B) of the Exchange Act,\8\ to extend
for a period not exceeding 240 days from the date of publication of
notice of the filing of a proposed rule change the period during which
the Commission must conclude proceedings to determine whether to
disapprove the proposal and to determine whether such longer period is
appropriate and publish the reasons for such determination; (6) to
temporarily suspend the PCAOB's proposed rule change pursuant to
Section 19(b)(3)(C) of the Exchange Act; \9\ (7) pursuant to Section
19(b)(2) of the Exchange Act and 19(b)(3) of the Exchange Act, to
institute proceedings to determine whether a proposed rule of the PCAOB
should be disapproved and to provide to the PCAOB notice of the grounds
for disapproval under consideration; and (8) to find good cause to
approve a proposal on an accelerated basis and to publish the reasons
for such determination.
---------------------------------------------------------------------------
\1\ See Section 107 of the Sarbanes-Oxley Act, 15 U.S.C. 7217.
\2\ See 15 U.S.C. 78s(b)(2).
\3\ Dodd-Frank Wall Street Reform and Consumer Protection Act,
Pub. L. 111-203, 124 Stat. 1376 (2010).
\4\ 15 U.S.C. 78s(b)(2). Section 107(b) of the Sarbanes Oxley
Act, 15 U.S.C. 7217(b), and Section 19(b)(2)(C) of the Exchange Act,
15 U.S.C. 78s(b)(2)(C), provide the standards for Commission
approval and disapproval of a proposed rule. Specifically, Section
107(b)(3) provides that the Commission ``shall approve a proposed
rule if it finds that the rule is consistent with the requirements
of this Act and the securities laws, or is necessary and appropriate
in the public interest or for the protection of investors.''
Additionally, the Commission may not approve a proposed rule change
earlier than 30 days after the date of publication unless the
Commission finds good cause for so doing and publishes the reasons
for the finding.
\5\ The amendments also specify that the Office of the Chief
Accountant is to notify the Commission no less than five (5)
business days before the Chief Accountant intends to exercise his or
her authority to approve or disapprove a particular proposed rule
change.
\6\ 15 U.S.C. 78s(b)(2)(A).
\7\ 15 U.S.C. 78s(b)(2)(A).
\8\ 15 U.S.C. 78s(b)(2)(B).
\9\ 15 U.S.C. 78s(b)(3)(C).
---------------------------------------------------------------------------
This delegation is intended to conserve Commission resources and
maintain the effectiveness and efficiency of the Commission's process
for handling proposed rule changes submitted by the PCAOB. The
Commission anticipates that the delegation of authority will help
facilitate timely compliance with the amendments to Section 19 of the
Exchange Act and the new statutory deadlines prescribed therein.
Nevertheless, the Chief Accountant may submit matters to the Commission
for its consideration, as he or she deems appropriate.
The Commission finds, in accordance with the Administrative
Procedure Act (5 U.S.C. 553(b)(3)(A)), that these amendments relate
solely to agency organization, procedures, or practices, and do not
relate to a substantive rule. Accordingly, notice, opportunity for
public comment, and publication of the amendments prior to their
effective date are unnecessary and these changes are effective on
January 18, 2011.
List of Subjects in 17 CFR Part 200
Administrative practice and procedure, Authority delegations
(Government agencies).
Text of Amendment
For the reasons set out in the preamble, Title 17, Chapter II of
the Code of Federal Regulations is amended as follows:
PART 200--ORGANIZATION; CONDUCT AND ETHICS; AND INFORMATION AND
REQUESTS
0
1. The authority citation for Part 200, Subpart A, continues to read in
part as follows:
Authority: 15 U.S.C. 77o, 77s, 77sss, 77d, 78d-1, 78d-2, 78w,
78ll(d), 78mm, 80a-37, 80b-11, and 7202 et seq., unless otherwise
noted.
* * * * *
0
2. Section 200.30-11 is amended as follows:
0
a. Redesignating paragraph (b) as paragraph (c).
0
b. Adding new paragraph (b).
The addition reads as follows:
Sec. 200.30-11 Delegation of authority to the Chief Accountant.
* * * * *
(b)(1) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002,
15 U.S.C. 7217, and section 19(b) of the Act, 15 U.S.C. 78s(b), and
applicable rules of the Commission, to publish notices of proposed rule
changes filed by the Public Company Accounting Oversight Board.
(2) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15
U.S.C. 7217, and section 19(b) of the Act, 15 U.S.C. 78s(b), and
applicable rules of the Commission, to approve or disapprove a proposed
rule change, and to find good cause to approve a proposed rule change
earlier than 30 days after the date of publication of such proposed
rule change and to publish the reasons for such finding. The Office of
the Chief Accountant shall notify the Commission no less than five (5)
business days before the Chief Accountant intends to exercise his or
her authority to approve or disapprove a particular proposed rule
change.
(3) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15
U.S.C. 7217, and section 19(b)(2)(A) of the Act, 15 U.S.C.
78s(b)(2)(A), to extend for a period not exceeding 90 days from the
date of publication of notice of the filing of a proposed rule change
pursuant to section 19(b)(1) of the Act, 15 U.S.C. 78s(b)(1), the
period during which the Commission must by order approve or disapprove
the proposed rule change or institute proceedings to determine whether
the proposed rule change should be disapproved and to determine whether
such longer period is appropriate and publish the reasons for such
determination.
(4) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15
U.S.C.
[[Page 2807]]
7217, section 19(b)(2) of the Act, 15 U.S.C. 78s(b)(2), and section
19(b)(3) of the Act, 15 U.S.C. 78s(b)(3), to institute proceedings to
determine whether a proposed rule change of the Public Company
Accounting Oversight Board should be disapproved and to provide to the
Public Company Accounting Oversight Board notice of the grounds for
disapproval under consideration. In addition, pursuant to section 107
of the Sarbanes-Oxley Act of 2002, 15 U.S.C. 7217, and section
19(b)(2)(B) of the Act, 15 U.S.C. 78s(b)(2)(B), to extend for a period
not exceeding 240 days from the date of publication of notice of the
filing of a proposed rule change pursuant to section 19(b)(1) of the
Act, 15 U.S.C. 78s(b)(1), the period during which the Commission must
issue an order approving or disapproving the proposed rule change and
to determine whether such longer period is appropriate and publish the
reasons for such determination.
(5) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15
U.S.C. 7217, and section 19(b)(3)(C) of the Act, 15 U.S.C.
78s(b)(3)(C), to temporarily suspend a rule of the Public Company
Accounting Oversight Board.
* * * * *
Dated: January 11, 2011.
By the Commission.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2011-835 Filed 1-14-11; 8:45 am]
BILLING CODE 8011-01-P